The Registration has been approved in Philippines for WALTZ™ Cobalt Alloy Stent System

Recently, the WALTZ™ Cobalt Alloy Stent System, which was produced by Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort^®") based on its independent R&D, had been approved for registration in Philippines with its first effort.

WALTZ™ Cobalt Alloy Stent System is composed of L605 cobalt alloy stent and a conveying system, mainly for the treatment of coronary artery stenosis or occlusion lesions. It is the third generation metal stents, following the Mustang™ and Tango™, produced by MicroPort^® with its independent R&D. WALTZ™ gained its CE certification in 2014 and obtained registration approval in Brazil, Argentina, Peru and other countries. Its approval of registration in Philippines this time will enrich the local coronary product line of MicroPort^® and accelerate the update of new products.